P36955 (PEDF_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Pigment epithelium-derived factor Short name=PEDF Alternative name(s): Cell proliferation-inducing gene 35 protein EPC-1 Serpin F1 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 418 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Neurotrophic protein; induces extensive neuronal differentiation in retinoblastoma cells. Potent inhibitor of angiogenesis. As it does not undergo the S (stressed) to R (relaxed) conformational transition characteristic of active serpins, it exhibits no serine protease inhibitory activity. Ref.12 Ref.13 |
| Subcellular location | Secreted. Melanosome. Note: Enriched in stage I melanosomes. Ref.16 |
| Tissue specificity | Retinal pigment epithelial cells and blood plasma. Ref.10 |
| Developmental stage | Expressed in quiescent cells. |
| Domain | The N-terminal (AA 44-121) exhibits neurite outgrowth-inducing activity. The C-terminal exposed loop (AA 382-418) is essential for serpin activity. |
| Post-translational modification | The N-terminus is blocked. Extracellular phosphorylation enhances antiangiogenic activity. N- and O-glycosylated. O-glycosylated with a core 1 or possibly core 8 glycan. Ref.15 Ref.17 Ref.18 Ref.20 |
| Involvement in disease | Defects in SERPINF1 are the cause of osteogenesis imperfecta type 12 (OI12) [MIM:613982]. OI12 is a connective tissue disorder characterized by bone fragility, low bone mass, and recurrent fractures. OI12 is characterized by features compatible with osteogenesis imperfecta type III in the Sillence classification. Patients have normal grayish sclerae and fractures of long bones and severe vertebral compression fractures, with resulting deformities observed as early as the first year of life. Ref.19 |
| Sequence similarities | Belongs to the serpin family. |
| Sequence caution | The sequence AAA84914.1 differs from that shown. Reason: Frameshift at position 356. The sequence AAA93524.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Secreted |
| Coding sequence diversity | Polymorphism |
| Disease | Osteogenesis imperfecta |
| Domain | Signal |
| PTM | Glycoprotein Phosphoprotein Pyrrolidone carboxylic acid |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | cell proliferation Traceable author statement. Source: ProtInc negative regulation of angiogenesisInferred from direct assay Ref.20. Source: UniProtKB positive regulation of neurogenesisInferred from direct assay Ref.12. Source: UniProtKB regulation of proteolysisInferred from Biological aspect of Ancestor. Source: RefGenome |
| Cellular component | extracellular space Inferred from direct assay. Source: BHF-UCL melanosomeInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | serine-type endopeptidase inhibitor activity Inferred from Biological aspect of Ancestor. Source: RefGenome |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 19 | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 20 – 418 | 399 | Pigment epithelium-derived factor | PRO_0000032508 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 371 – 383 | 13 | O-glycosylated at one site | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 20 | 1 | Pyrrolidone carboxylic acid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 24 | 1 | Phosphoserine; by CK2 Ref.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 114 | 1 | Phosphoserine; by CK2 Ref.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 227 | 1 | Phosphoserine; by PKA Ref.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 285 | 1 | N-linked (GlcNAc...) Ref.15 Ref.17 Ref.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 72 | 1 | T → M. Ref.1 Ref.2 Ref.3 Ref.5 Ref.7 Ref.8 Ref.9 Ref.11 Ref.21 Corresponds to variant rs1136287 [ dbSNP | Ensembl ]. | VAR_009126 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 132 | 1 | P → R. Ref.8 Corresponds to variant rs1804145 [ dbSNP | Ensembl ]. | VAR_025500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 97 – 98 | 2 | EQ → DE in AAA60058. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 97 – 98 | 2 | EQ → DE in AAB38685. Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 45 – 48 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 50 – 72 | 23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 78 – 80 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 82 – 92 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 93 – 95 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 98 – 107 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 110 – 112 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 118 – 129 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 136 – 144 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 152 – 162 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 173 – 187 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 188 – 190 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 204 – 214 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 217 – 219 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 223 – 225 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 227 – 236 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 238 – 256 | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 257 – 260 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 261 – 268 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 269 – 271 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 272 – 281 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 287 – 290 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 295 – 304 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 306 – 315 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 317 – 324 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 326 – 330 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 331 – 335 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 336 – 339 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 344 – 346 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 353 – 364 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 368 – 370 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 387 – 389 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 394 – 400 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 401 – 403 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 406 – 413 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family." Steele F.R., Chader G.J., Johnson L.V., Tombran-Tink J. Proc. Natl. Acad. Sci. U.S.A. 90:1526-1530(1993) [PubMed: 8434014] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, VARIANT MET-72. Tissue: Fetal eye. |
| [2] | "Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin." Tombran-Tink J., Mazuruk K., Rodriguez I.R., Chung D., Linker T., Englander E., Chader G.J. Mol. Vis. 2:11-11(1996) [PubMed: 9238088] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT MET-72. |
| [3] | Yin B., Peng X., Yuan J., Qiang B. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT MET-72. |
| [4] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "Identification of a human cell proliferation inducing gene." Kim J.W. Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT MET-72. Tissue: Liver cancer. |
| [6] | "DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage." Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., Chang J.L. Nusbaum C.Nature 440:1045-1049(2006) [PubMed: 16625196] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT MET-72. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS MET-72 AND ARG-132. Tissue: Muscle. |
| [9] | Coljee V.W. Thesis (1996), Medical College of Pennsylvania, United States Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-332, VARIANT MET-72. Tissue: Fetal lung fibroblast. |
| [10] | "Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization." Petersen S.V., Valnickova Z., Enghild J.J. Biochem. J. 374:199-206(2003) [PubMed: 12737624] [Abstract] Cited for: PROTEIN SEQUENCE OF 21-29; 253-262 AND 282-303, TISSUE SPECIFICITY, PYROGLUTAMATE FORMATION AT GLN-20. Tissue: Plasma. |
| [11] | "Senescent WI-38 cells fail to express EPC-1, a gene induced in young cells upon entry into the G0 state." Pignolo R.J., Cristofalo V.J., Rotenberg M.O. J. Biol. Chem. 268:8949-8957(1993) [PubMed: 8473338] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 60-418, VARIANT MET-72. Tissue: Fetal lung fibroblast. |
| [12] | "Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor." Becerra S.P., Palmer I., Kumar A., Steele F.R., Shiloach J., Notario V., Chader G.J. J. Biol. Chem. 268:23148-23156(1993) [PubMed: 8226833] [Abstract] Cited for: FUNCTION. |
| [13] | "Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop." Becerra S.P., Sagasti A., Spinella P., Notario V. J. Biol. Chem. 270:25992-25999(1995) [PubMed: 7592790] [Abstract] Cited for: FUNCTION. |
| [14] | "Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor." Maik-Rachline G., Shaltiel S., Seger R. Blood 105:670-678(2005) [PubMed: 15374885] [Abstract] Cited for: PHOSPHORYLATION AT SER-24; SER-114 AND SER-227. |
| [15] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-285, MASS SPECTROMETRY. Tissue: Plasma. |
| [16] | "Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes." Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F. J. Proteome Res. 5:3135-3144(2006) [PubMed: 17081065] [Abstract] Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. Tissue: Melanoma. |
| [17] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-285, MASS SPECTROMETRY. Tissue: Liver. |
| [18] | "Enrichment of glycopeptides for glycan structure and attachment site identification." Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E., Brinkmalm G., Larson G. Nat. Methods 6:809-811(2009) [PubMed: 19838169] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS], STRUCTURE OF CARBOHYDRATES, MASS SPECTROMETRY. Tissue: Cerebrospinal fluid. |
| [19] | "Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta." Becker J., Semler O., Gilissen C., Li Y., Bolz H.J., Giunta C., Bergmann C., Rohrbach M., Koerber F., Zimmermann K., de Vries P., Wirth B., Schoenau E., Wollnik B., Veltman J.A., Hoischen A., Netzer C. Am. J. Hum. Genet. 88:362-371(2011) [PubMed: 21353196] [Abstract] Cited for: INVOLVEMENT IN OI12. |
| [20] | "Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor." Simonovic M., Gettins P.G.W., Volz K. Proc. Natl. Acad. Sci. U.S.A. 98:11131-11135(2001) [PubMed: 11562499] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 21-418, GLYCOSYLATION AT ASN-285. |
| [21] | "Four polymorphic variations in the PEDF gene identified during the mutation screening of patients with Leber congenital amaurosis." Koenekoop R., Pina A.L., Loyer M., Davidson J., Robitaille J., Maumenee I., Tombran-Tink J. Mol. Vis. 5:10-10(1999) [PubMed: 10398730] [Abstract] Cited for: VARIANT MET-72. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M76979 mRNA. Translation: AAA60058.1. U29953 Genomic DNA. Translation: AAA84914.1. Frameshift. AF400442 mRNA. Translation: AAK92491.1. BT007222 mRNA. Translation: AAP35886.1. AY513280 mRNA. Translation: AAT08033.1. AC130343 Genomic DNA. No translation available. AC130689 Genomic DNA. No translation available. CH471108 Genomic DNA. Translation: EAW90577.1. BC000522 mRNA. Translation: AAH00522.1. BC013984 mRNA. Translation: AAH13984.1. U57450 U57449 Genomic DNA. Translation: AAB38685.1.M90439 mRNA. Translation: AAA93524.1. Different initiation. | ||||||||||||
| IPI | IPI00006114. | ||||||||||||
| PIR | A46046. A47281. | ||||||||||||
| RefSeq | NP_002606.3. NM_002615.5. | ||||||||||||
| UniGene | Hs.532768. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P36955. | ||||||||||||
| SMR | P36955. Positions 36-418. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P36955. 1 interaction. | ||||||||||||
| STRING | P36955. | ||||||||||||
Protein family/group databases | |||||||||||||
| MEROPS | I04.979. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P36955. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 20178323. | ||||||||||||
2D gel databases | |||||||||||||
| Cornea-2DPAGE | P36955. | ||||||||||||
| REPRODUCTION-2DPAGE | IPI00006114. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | P36955. | ||||||||||||
| PRIDE | P36955. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000254722; ENSP00000254722; ENSG00000132386. | ||||||||||||
| GeneID | 5176. | ||||||||||||
| KEGG | hsa:5176. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 5176. | ||||||||||||
| GeneCards | GC17P001612. | ||||||||||||
| H-InvDB | HIX0013408. | ||||||||||||
| HGNC | HGNC:8824. SERPINF1. | ||||||||||||
| HPA | CAB004785. HPA005825. | ||||||||||||
| MIM | 172860. gene. 613982. phenotype. | ||||||||||||
| neXtProt | NX_P36955. | ||||||||||||
| PharmGKB | PA35508. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG09045. | ||||||||||||
| GeneTree | ENSGT00560000076649. | ||||||||||||
| HOGENOM | HBG278447. | ||||||||||||
| HOVERGEN | HBG106911. | ||||||||||||
| InParanoid | P36955. | ||||||||||||
| OMA | LNCKIAQ. | ||||||||||||
| OrthoDB | EOG44J2JG. | ||||||||||||
| PhylomeDB | P36955. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P36955. | ||||||||||||
| Bgee | P36955. | ||||||||||||
| CleanEx | HS_SERPINF1. | ||||||||||||
| Genevestigator | P36955. | ||||||||||||
| GermOnline | ENSG00000132386. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR000215. Protease_inhib_I4_serpin. IPR023795. Protease_inhib_I4_serpin_CS. IPR023796. Sepin_dom. [Graphical view] | ||||||||||||
| PANTHER | PTHR11461. Prot_inh_serpin. 1 hit. | ||||||||||||
| Pfam | PF00079. Serpin. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00093. SERPIN. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF56574. Prot_inh_serpin. 1 hit. | ||||||||||||
| PROSITE | PS00284. SERPIN. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | PEDF_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P36955 Secondary accession number(s): Q13236 Q9BWA4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with